Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-12-19
1999-04-27
MacMillan, Keith D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514570, 514616, 514814, 514825, 528328, A61K 3119, A61K 3154
Patent
active
058980334
ABSTRACT:
An anti-inflammatory conjugate including a polyamino acid backbone, a non-steroidal anti-inflammatory agent, and a moiety linking the anti-inflammatory agent to the backbone, wherein the polyamino acid backbone has a molecular weight greater than 250 kD.
REFERENCES:
patent: 4151173 (1979-04-01), Vogel
patent: 4349530 (1982-09-01), Royer
patent: 4356166 (1982-10-01), Peterson et al.
patent: 4386026 (1983-05-01), Ponpipom et al.
patent: 5030834 (1991-07-01), Krumdieck et al.
patent: 5118784 (1992-06-01), Kubota et al.
patent: 5225182 (1993-07-01), Sharma
De Marre, et al., "Evaluation of the hydrolytic and enzymatic stability of macromolecular Mitomyci C derivatives", Journal of Controlled Release, 31:89-97, (1994).
Franssen, et al., "Hepatic and Intrahepatic Targeting . . . And Neoglycoproteins As Carrier Molecules", Biochemical Pharmacology, 45:1215-1226, (1993).
Liso, et al., "Antinociceptive and antipyretic properties . . . controlled delivery system", Journal of Controlled Release, 33:429-436, (1994).
Roos, et al., "Physicochemical and antitumor . . . of mitomycin C", International Journal of Pharmaceutics, 22:75-87, (1984).
van Heeswijk, et al., "The Synthesis and Characterization of Polypeptide . . . with Adriamycin. Part 1", Journal of Controlled Release, 1:301-315, (1985).
Anderson, "In Vitro and In Vivo Studies of Drug-Releasing Poly(amino acids)," Annals New York Academy of Sciences, 67-75 (1985).
Borbely et al., "Biosynthesis and Chemical Modification of Poly( -glutamic acid)," Polymer Bulletin 32, 127-132 (1994).
Goodman et al., "Immunochemical Studies on the Poly--D-glutamyl Capsule of Bacillus Anthracis. I. Characterization of the Polypeptide and of the Specificity of Its Reaction With Rabbit Antisera," Biochemistry 5, No. 2 657-664 (1966).
Goodman et al., "Immunochemical Studies on the Poly--D-glutamyl Capsule of Bacillus Anthracis. III. The Activity with Rabbit Antisera of Peptides Derived from the Homologous Polypeptide," Biochemistry 7, No. 2 706-710 (1968).
Jensen et al., "Production of Recombinant Human Growth Hormone in Escherichia coli: Expression of Different Precursors and Physiological Effects of Glucose, Acetate, and Salts," Biotechnology and Bioengineering, 36 1-11 (1990).
Nitecki et al., "Immunochemical Studies on the Poly( -glutamyl Capsule of Bacillus anthracis. II. The Synthesis of Eight Dipeptides and Four Tripeptides of Glutamic Acid," Biochemistry 5, 665-672 (1966).
Shah et al., "New Polymers Derived From Natural Origin -Poly(Glutamic Acid)," Polymer Preprints, 33 No. 2 488-490 (1992).
Thorne et al., "Production of Glutamyl Polypeptide By Bacillus Subtilis," Journal of Bacteriology, 68 307-315 (1954).
Tsukada et al., "An Anti-.alpha.-Fetoprotein Antibody-Daunorubicin Conjugate With A Novel Poly-L-glutamic Acid Derivative as Intermediate Drug Carrier," JNCI, 73, No. 3 721-729 (1984).
Sevoian Martin
Swadesh Joel K.
LandOfFree
Antigen-processing cell-targeted conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antigen-processing cell-targeted conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigen-processing cell-targeted conjugates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-685732